The patient was diagnosed with chronic phase CML with the Ph chromosome and the P210 subtype of BCR-ABL, 1 year after AIHA was diagnosed. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.